ReviewExtracellular vesicles and circulating nucleic acids2025
Extracellular vesicles from bacteria and fungi: mechanistic insights and implications for urinary tract infections.
Review in Extracellular vesicles and circulating nucleic acids, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Urinary tract infections (UTIs) pose a significant public health challenge, affecting approximately 407 million people worldwide and causing substantial morbidity and approximately 237,000 deaths. Bacteria and fungi represent the most frequent causative microbes, leading to symptoms such as low abdominal pain, fever, frequent urination, hematuria, sepsis, inflammation of the bladder and kidney, and even death. In recent years, extracellular vesicles (EVs) have emerged as critical mediators of UTI pathogenesis. EVs are lipid bilayer nanoscale particles that carry DNA, RNA, enzymes, and other biomolecules. They can facilitate microbial colonization, immune modulation and evasion, tissue invasion, and antimicrobial agent resistance. This review summarizes current knowledge on the role of bacterial and fungal-derived EVs in UTIs, their mechanisms of action, and their potential therapeutic implications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.